Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gabriele De Maio
Observed name:
G De Maio
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico,
University of Naples Federico II
ORCID:
0009-0000-1985-8224
Observed ORCID:
0009-0000-1985-8224
OpenAlex ID:
A5102714945
Correlation between inflammatory biomarkers and disease control in chronic rhinosinusitis with nasal polyps
2024
·
Eugenio De Corso
, Silvia Baroni
, et al.
·
International Forum of Allergy & Rhinology
·
33
PDF
Two‐Year Turning Point With Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Control, Remission, and Tapering Dosage
2025
·
Eugenio De Corso
, Claudio Montuori
, et al.
·
Allergy
·
29
Comparative real‐world outcomes of dupilumab versus endoscopic sinus surgery in the treatment of severe CRSwNP patients
2024
·
Eugenio De Corso
, Davide Paolo Porru
, et al.
·
Clinical Otolaryngology
·
26
PDF
Temporal trends of blood eosinophilia in severe uncontrolled CRSwNP treated with dupilumab: a real-life study
2023
·
Eugenio De Corso
, Claudio Montuori
, et al.
·
European Archives of Oto-Rhino-Laryngology
·
20
Effectiveness of Dupilumab in the Treatment of Adult and Older Adult Patients with Severe, Uncontrolled CRSwNP
2023
·
Giancarlo Ottaviano
, Eugenio De Corso
, et al.
·
Journal of Personalized Medicine
·
17
PDF
Sinonasal Outcomes Obtained after 2 Years of Treatment with Benralizumab in Patients with Severe Eosinophilic Asthma and CRSwNP: A “Real-Life” Observational Study
2024
·
Eugenio De Corso
, Dario Antonio Mele
, et al.
·
Journal of Personalized Medicine
·
13
PDF
Dupilumab Monthly Dose De‐Escalation Maintains Efficacy in CRSwNP : A Two‐Year Real‐World Study
2025
·
Eugenio De Corso
, Claudio Montuori
, et al.
·
The Laryngoscope
·
10
Low dose oral corticosteroids, microneedling, and topical 5‐fluorouracil: A novel treatment for recalcitrant pediatric vitiligo
2020
·
Claudio Marasca
, Gabriella Fabbrocini
, et al.
·
Pediatric Dermatology
·
10
One year mepolizumab outcomes in severe, uncontrolled CRSwNP: a real-life study.
2025
·
E De Corso
, M Corbi
, et al.
·
PubMed
·
7
Dupilumab-Induced Blood Eosinophilia in Patients With Chronic Rhinosinusitis With Nasal Polyps: Temporal Trends and Correlation With Adverse Events
2025
·
Eugenio De Corso
, Claudio Montuori
, et al.
·
The Journal of Allergy and Clinical Immunology In Practice
·
7
Role of body mass index as a predictor of dupilumab efficacy in patients with severe chronic rhinosinusitis with nasal polyps
2025
·
Letizia Nitro
, Eugenio De Corso
, et al.
·
Acta Otorhinolaryngologica Italica
·
4
PDF
Influence of Multiple Prior Endoscopic Sinus Surgeries on Dupilumab Efficacy Including Smell Function in the DUPIREAL Population
2025
·
Eugenio De Corso
, Claudio Montuori
, et al.
·
Clinical Otolaryngology
·
3
A case of Stewart–Treves Syndrome of the lower limbs: The usefulness of dermoscopy
2019
·
Claudio Marasca
, Giuseppina Fontanella
, et al.
·
International Wound Journal
·
2
Show more works
View as search
Works count:
13
Citation count:
181
H-index:
8
I10-index:
8
Year
Topic
Type